Novel central nervous system drug delivery systems.

Area of Science:

• Biomedical research
• Neuroscience
• Drug delivery systems

Background:

• The blood-brain barrier (BBB) severely limits drug penetration to the central nervous system (CNS), hindering effective treatment for neurological disorders.
• Less than 1% of most drugs reach the CNS, resulting in a lack of viable therapeutic options for conditions such as stroke, neurodegenerative diseases, and brain tumors.

Purpose of the Study:

• To review and assess novel drug delivery strategies designed to overcome the BBB.
• To evaluate the clinical applications, limitations, and current research status of these advanced delivery methods.

Main Methods:

• Review of emerging drug delivery techniques for CNS disorders.
• Analysis of intranasal delivery, nanoparticles, drug modifications, convection-enhanced infusion, and ultrasound-mediated delivery.
• Assessment of preclinical and clinical research for each method.

Main Results:

• Several novel strategies show significant promise for enhancing drug delivery across the BBB.
• These approaches offer potential for more effective and safer therapeutic interventions for CNS diseases.
• The review details specific applications and limitations of each discussed delivery technique.

Conclusions:

• Advancements in drug delivery systems are crucial for improving the treatment of central nervous system diseases.
• These novel methods hold the potential to revolutionize therapies for stroke, neurodegenerative disorders, and brain tumors.
• Further research and clinical translation are expected to yield improved patient outcomes.